Expiration Date: 04/19/2023
Learner Notification
*Please note that you must complete the Post Webinar Evaluation (link below) to receive CE credit.
Speakers
Rais Vorah, MD, FACEP, FACMT
Professor of Clinical Emergency Medicine and Clinical Pharmacy
Medical Director, California Poison Control System Fresno-Madera Division
Interim Health Officer, Fresno County Department of Public Health
Has disclosed no relevant financial relationships
Haylee Veazey, MD
Assistant Professor of Medicine
Assistant Professor of Emergency Medicine
Hennepin Healthcare
Has disclosed no relevant financial relationships
Moderator
Alexandra R. Funk, PharmD, DABAT
Managing Director
Florida Poison Information Center – Tampa
Has disclosed no relevant financial relationships
Garret A. Winkler, MD
Medical Toxicology Fellow
University of California San Diego
Has disclosed no relevant financial relationships
Organizer
Shawn M. Varney, MD, FAACT, FACEP, FACMT
Professor of Emergency Medicine
Medical Director, South Texas Poison Center
University of Texas Health Science Center San Antonio
Has disclosed no relevant financial relationships
Description
The speakers will discuss the importance and relevance of Diversity, Equity, and Inclusion to AACT members including clinical and medical toxicologists. They will also provide insight on how DEI directly relates to poison centers, the management of toxicology patients, and toxicologists.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire webinar as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Physicians and Pharmacists
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Academy of Clinical Toxicology. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM for physicians and 1 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of the activity to meet the deadline for submission to CPE Monitor.
Objectives – After attending this program you should be able to:
- Understand ways that frames and filters can stigmatize people who are seeking health care.
- Understand the principles of harm reduction
- To identify pronoun usage and incorporate it into your practice.
- To identify common gender affirming medications and side effects.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.
Click here to complete the Post Webinar CE Evaluation